Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2

Journal of Endocrinology

Volumn 213, Issue 3, 2012, Pages 277-284

  Baldassano, Sara ^a   Bellanca, Anna Lisa ^a   Serio, Rosa ^a   Mulé, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2;

ANIMAL EXPERIMENT; ARTICLE; FOOD INTAKE; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STOMACH EMPTYING;

ANIMALS; APPETITE DEPRESSANTS; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; GASTRIC EMPTYING; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; MALE; MICE; MICE, INBRED C57BL; OBESITY; PEPTIDE FRAGMENTS; RECEPTOR CROSS-TALK; RECEPTORS, GLUCAGON; TIME FACTORS;

EID: 84864305183     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0092     Document Type: Article

References (46)

1. Amato A, Baldassano S, Serio R & Mulé F 2009 Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. American Journal of Physiology. Gastrointestinal and Liver Physiology 296 G678-G684.
2. Amato A, Rotondo A, Cinci L, Baldassano S, Vannucchi MG & Mulé F 2010 Role of cholinergic neurons in the motor effects of glucagonlike peptide-2 in mouse colon. American Journal of Physiology. Gastrointestinal and Liver Physiology 299 G1038-G1044.
3. Baldassano S, Liu S, Qu MH, Mulé F & Wood JD 2009 Glucagon-like peptide-2 modulates neurally-evoked mucosal chloride secretion in guinea pig small intestine in vitro. American Journal of Physiology. Gastrointestinal and Liver Physiology 297 G800-G805.
4. Brubaker PL 2006 The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis. Annals of the New York Academy of Sciences 1070 10-26.
5. Burrin DG, Stoll B & Guan X 2003 Glucagon-like peptide 2 function in domestic animals. Domestic Animal Endocrinology 24 103-122.
6. Cinci L, Faussone-Pellegrini MS, Rotondo A, Mulé F & Vannucchi MG 2011 GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterology and Motility 23 383-392.
7. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA & Bloom SR 2003 Oxyntomodulin suppresses appetite and reduces food intake in humans. Journal of Clinical Endocrinology and Metabolism 88 4696-4701.
8. Collins S, Martin TL, Surwit RS & Robidoux J 2004 Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiology & Behavior 81 243-248.
9. Covasa M & Ritter RC 1998 Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 19 1407-1415.
10. Covasa M, Marcuson JK & Ritter RC 2001 Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 280 R331-R337.
11. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA & Bloom SR 2001 Oxyntomodulin inhibits food intake in the rat. Endocrinology 142 4244-4250.
12. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA & Bloom SR 2004 Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145 2687-2695.
13. Drucker DJ, Shi Q, Crivici A, Sumner-Smith M, Tavares W, Hill M, DeForest L, Cooper S & Brubaker PL 1997 Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nature Biotechnology 15 673-677.
14. Estall JL & Drucker DJ 2006 Glucagon-like peptide-2. Annual Review of Nutrition 26 391-411.
15. Flint A, Raben A, Astrup B & Holst JJ 1998 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Journal of Clinical Investigation 101 515-520.
16. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J & Göke B 1993 Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Journal of Biological Chemistry 268 19650-19655.
17. Hansen L, Hare KJ, Hartmann B, Deacon CF, Ugleholdt RK, Plamboeck A & Holst JJ 2007 Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IV. Regulatory Peptides 138 126-132.
18. Hartmann B, Thulesen J, Kissow H, Thulesen S, Orskov C, Ropke C, Poulsen SS & Holst JJ 2000 Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141 4013-4020.
19. Jeppensen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ et al. 2001 Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120 806-815.
20. Lin S, Thomas TC, Storlien LH & Huang XF 2000 Development of high fat diet induced obesity and leptin resistance in C57Bl/6J mice. International Journal of Obesity 5 639-646.
21. Liu Y-L, Ford HE, Druce MR, Minnion JS, Field BCT, Schillito JC, Baxter J, Murphy KG, Ghatei MA & Bloom SR 2010 Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. International Journal of Obesity 34 1715-1725.
22. Lovshin J, Estall J, Yusta B, Brown TJ & Drucker DJ 2001 Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. Journal of Biological Chemistry 276 21489-21499.
23. Lovshin JA, Huang Q, Seaberg R, Brubaker PL & Drucker DJ 2004 Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells. Endocrinology 145 3495-3506.
24. McDonagh SC, Lee J, Izzo A & Brubaker PL 2007 Role of glial cell-line derived neurotropic factor family receptor a2 in the actions of the glucagon-like peptides on the murine intestine. American Journal of Physiology. Gastrointestinal and Liver Physiology 293 G461-G468.
25. Munroe DG, Gupta AK, Kooshesh F, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K et al. 1999 Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. PNAS 96 1569-1573.
26. Nagell CF, Wettergren A, Pedersen JF, Mortensen D & Holst JJ 2004 Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scandinavian Journal of Gastroenterology 39 353-358.
27. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS et al. 2005 Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 146 5120-5127.
28. Nefti W, Chaumontet C, Fromentin G, Tomé D & Darcel N 2009 A high-fat diet attenuates the central response to within-meal satiation signals and modifies the receptor expression of vagal afferents in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 296 R1681-R1686.
29. Nelson DW, Sharp JW, Brownfield MS, Raybould HE & Ney DM 2007 Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 148 1954-1962.
30. Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E & Stricker-Krongrad A 2004 Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. International Journal of Obesity 28 879-885.
31. Rotondo A, Amato A, Baldassano S, Lentini L & Mulé F 2011 Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 32 1587-1592.
32. Rowland KJ & Brubaker PL 2011 The "cryptic" mechanism of action of glucagon-like peptide-2. American Journal of Physiology. Gastrointestinal and Liver Physiology 301 G1-G8.
33. Schmidt PT, Näslund E, Grybäck P, Jacobsson H, Hartmann B, Holst JJ & Hellström PM 2003 Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety. Regulatory Peptides 116 21-25.
34. Scott RB, Kirk D, MacNaughton WK &Meddings JB 1998 GLP-2 augments the adaptive response to massive intestinal resection in rat. American Journal of Physiology 275 G911-G921.
35. Shin ED, Estall JL, Izzo A, Drucker DJ & Brubaker PL 2005 Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128 1340-1353.
36. Shousha S, Nakahara K, Nasu T, Sakamoto T & Murakami N 2007 Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the Japanese quail. Neuroscience Letters 415 102-107.
37. Sorensen LB, Flint A, Raben A, Hartmann B, Holst JJ & Astrup A 2003 No effect of physiological concentrations of glucagonlike peptide-2 on appetite and energy intake in normal weight subjects. International Journal of Obesity and Related Metabolic Disorders 27 450-456.
38. Talsania T, Anini Y, Siu S, Drucker DJ & Brubaker PL 2005 Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146 3748-3756.
39. Tang-Christensen M, Larsen PJ, Thulesen J, Rømer J & Vrang N 2000 The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nature Medicine 6 802-807.
40. Tsai CH, Hill M, Asa SL, Brubaker PL & Drucker DJ 1997 Intestinal growth promoting properties of glucagon-like peptide-2 in mice. American Journal of Physiology 273 E77-E84.
41. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM & Meeran K 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 69-72.
42. Verdich C, Flint A, Gutzwiller JP, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ & Astrup A 2001 A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Journal of Clinical Endocrinology and Metabolism 86 4382-4389.
43. Vrang N & Larsen PJ 2010 Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides. Progress in Neurobiology 92 442-462.
44. Wheeler MB, Gelling RW, McIntosh CH, Georgiou J, Brown JC & Pederson RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology 136 4629-4639.
45. Whitcomb DC, Taylor IL & Vigna SR 1990 Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. American Journal of Physiology 259 G687-G691.
46. Wøjdemann M, Wettergren A, Hartmann B & Holst JJ 1998 Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scandinavian Journal of Gastroenterology 33 828-832.